Related Experiment Videos
[Unusual course of a status epilepticus. (Case contribution to the problem of "interparoxysmal petit-mal-status")]
Abstract:
This is a record of a strange course of the petit mal status which persisted for almost four days following a series of grands maux. During the status, it was possible to observe in electroencephalogram a 2-2.5/sec and, finally, 2.5-3.5/sec spike and wave pattern which could be interrupted after the administration of 100 mg of diazepam. In contrast with the normally observed twilight state, this particular course of the petit mal status ("interparoxysmal petit mal status") is characterized by a marked disturbance of consciousness. There was no response to an intravenous administration of 750 mg of diphenylhydantoin.
Insights
This case study details a rare four-day petit mal status epilepticus. Diazepam temporarily controlled the abnormal EEG patterns, but consciousness remained disturbed.
Area of Science:
- Neurology
- Epileptology
Background:
- Petit mal status epilepticus (PS) is a rare condition characterized by continuous or recurrent absence seizures.
- This case presents an unusual prolonged course of PS following generalized tonic-clonic seizures (grands maux).
Observation:
- The patient experienced a four-day episode of petit mal status epilepticus.
- Electroencephalogram (EEG) revealed a persistent spike and wave pattern (2-2.5/sec, then 2.5-3.5/sec).
Findings:
- Diazepam (100 mg) temporarily interrupted the EEG abnormalities.
- Intravenous diphenylhydantoin (750 mg) was ineffective in controlling the status.
- The condition, termed 'interparoxysmal petit mal status,' presented with significant disturbance of consciousness, differing from typical twilight states.
Implications:
- This case highlights the variable clinical presentations and treatment responses in petit mal status epilepticus.
- It underscores the importance of EEG monitoring in diagnosing and managing prolonged seizure states.
- Further research may be needed to understand the specific mechanisms and optimal treatments for this rare form of epilepsy.